STRONGBRIDGE BIOPHARMA PLC's ticker is SBBP and the CUSIP is G85347105. A total of 50 filers reported holding STRONGBRIDGE BIOPHARMA PLC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $28,000 | -71.1% | 11,591 | -52.9% | 0.00% | – |
| Q2 2020 | $97,000 | +162.2% | 24,589 | +24.8% | 0.00% | – |
| Q1 2020 | $37,000 | +362.5% | 19,710 | +1327.2% | 0.00% | – |
| Q2 2018 | $8,000 | -96.1% | 1,381 | -94.1% | 0.00% | – |
| Q1 2018 | $206,000 | +32.1% | 23,272 | +8.1% | 0.00% | – |
| Q4 2017 | $156,000 | +18.2% | 21,530 | +12.7% | 0.00% | – |
| Q3 2017 | $132,000 | +1785.7% | 19,098 | +1921.0% | 0.00% | – |
| Q2 2017 | $7,000 | +40.0% | 945 | -7.5% | 0.00% | – |
| Q1 2017 | $5,000 | +150.0% | 1,022 | 0.0% | 0.00% | – |
| Q4 2016 | $2,000 | -60.0% | 1,022 | 0.0% | 0.00% | – |
| Q3 2016 | $5,000 | +25.0% | 1,022 | 0.0% | 0.00% | – |
| Q2 2016 | $4,000 | -20.0% | 1,022 | 0.0% | 0.00% | – |
| Q1 2016 | $5,000 | – | 1,022 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 8,083,442 | $22,310,000 | 14.49% |
| AIGH Capital Management LLC | 2,194,173 | $6,056,000 | 1.27% |
| Worth Venture Partners, LLC | 550,196 | $1,519,000 | 0.74% |
| Stonepine Capital Management, LLC | 445,701 | $1,230,000 | 0.66% |
| NEA Management Company, LLC | 4,141,308 | $11,430,000 | 0.26% |
| Ikarian Capital, LLC | 1,160,450 | $3,203,000 | 0.11% |
| ALGERT GLOBAL LLC | 99,397 | $274,000 | 0.09% |
| Zebra Capital Management LLC | 24,039 | $66,000 | 0.07% |
| HighVista Strategies LLC | 28,432 | $79,000 | 0.06% |
| Orbimed Advisors | 1,744,669 | $4,815,000 | 0.04% |